期刊文献+

Synthesis, Crystal Structure and Na^+/K^+-ATPase Inhibitory Activity of △^(14,15)-anhydro-24-thiocarbonylbufalin

Synthesis, Crystal Structure and Na^+/K^+-ATPase Inhibitory Activity of △^(14,15)-anhydro-24-thiocarbonylbufalin
下载PDF
导出
摘要 The title compound △14,15-anhydro-24-thiocarbonylbufalin (1) was prepared by the reaction of natural product bufalin with Lawesson reagent. The crystal structure of 1, C24H3002S'C24H3002S, was determined by single-crystal X-ray diffraction analysis. It belongs to monoclinic, space group C2, with a = 30.9845(2), b = 6.8036(3), c = 22.5791(15)/k, V= 4241.7(4) A3, Mr = 384.21, Z = 4, Dc= 1.204 g/cm3,μ = 1.463 mm4, F(000) = 1664, S = 1.064, R = 0.0487 and wR = 0.0645 for 4683 unique reflections, of which 3757 were observed (I 〉 2σ(/)). The asymmetric unit contains two independent molecules (ⅠandⅡ), which are closely similar to each other except for the orientation of the lactone ring. Both conformations of I and II are in good agreement with the solution structure in methanol as indicated by 1H-NMR analysis. Due to the presence of heavy atom sulfur in the molecules, the final refinement resulted in a small Flack parameter 0.02(3), permitting the assignments of the absolute configuration. In the solid state, intermolecular hydrogen bonds involving thiocarbonyl group in the lactone moiety and the hydroxyl groups in the steroid moiety ester linked adjacent molecules into a three-dimensional network. Compound 1 showed weak inhibition on Na+/K+-ATPase in contrast to the strong inhibitory activity of the parent compound bufalin, suggesting that the carbonyl group in lactone moiety and the hydroxyl group atC-14 play important roles for the inhibition of Na+/K*-ATPase. The title compound △14,15-anhydro-24-thiocarbonylbufalin (1) was prepared by the reaction of natural product bufalin with Lawesson reagent. The crystal structure of 1, C24H3002S'C24H3002S, was determined by single-crystal X-ray diffraction analysis. It belongs to monoclinic, space group C2, with a = 30.9845(2), b = 6.8036(3), c = 22.5791(15)/k, V= 4241.7(4) A3, Mr = 384.21, Z = 4, Dc= 1.204 g/cm3,μ = 1.463 mm4, F(000) = 1664, S = 1.064, R = 0.0487 and wR = 0.0645 for 4683 unique reflections, of which 3757 were observed (I 〉 2σ(/)). The asymmetric unit contains two independent molecules (ⅠandⅡ), which are closely similar to each other except for the orientation of the lactone ring. Both conformations of I and II are in good agreement with the solution structure in methanol as indicated by 1H-NMR analysis. Due to the presence of heavy atom sulfur in the molecules, the final refinement resulted in a small Flack parameter 0.02(3), permitting the assignments of the absolute configuration. In the solid state, intermolecular hydrogen bonds involving thiocarbonyl group in the lactone moiety and the hydroxyl groups in the steroid moiety ester linked adjacent molecules into a three-dimensional network. Compound 1 showed weak inhibition on Na+/K+-ATPase in contrast to the strong inhibitory activity of the parent compound bufalin, suggesting that the carbonyl group in lactone moiety and the hydroxyl group atC-14 play important roles for the inhibition of Na+/K*-ATPase.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2014年第8期1123-1128,共6页 结构化学(英文)
基金 supported by the National Natural Science Foundation of China(81102518)
关键词 crystal structure △14 15-anhydro-24-thiocarbonylbufalin Na+/K+-ATPase crystal structure, △14,15-anhydro-24-thiocarbonylbufalin, Na+/K+-ATPase
  • 相关文献

参考文献17

  • 1China Pharmacopoeia Committee. Chinese Pharmacopoeia (2010 edition). Chemical Industry Press: Beijing 2010, p. 360.
  • 2Steyn, E S.; van Heerden, E R. Bufadienolides of plant and animal origin. Nat. Prod. Rep. 1998, 15, 397-413.
  • 3Oao, H. M.; Popeseu, R.; Kopp, B.; Wang, Z. M. Bufadienolidcs and their antitumor activity. Nat. Prod. Rep. 2011, 28, 953-969.
  • 4Belanger, A.; Brassard, E; Dionne, G; Engel, C. R. Steroids and related products. XL. novel bufadienolide synthesis. Steroids 1974, 24, 377-385.
  • 5Sondheimer, F.; McCrae, W.; Salmon& W. G. Synthesis of bufadicnolides: synthesis of bufalin and resibufoganin. J. Am. Chem. Soc. 1969, 91,1228-1230.
  • 6Zhou, M. T.; Hou, Y. P.; Hamza, A.; Zhan, C. G; Bugni, T. S.; Thorson, J. S. Probing the regiospccificity of enzyme-catalyzed steroid glycosylation. Org. Lett. 2012, 14, 5424-5427.
  • 7Zhan, J. X.; Guo, H. Z.; Ning, L. L.; Zhang, Y. X.; Guo, D. A. Efficient preparation of derivatives of rcsibufogcnin using microbial catalytic technique Planta Med. 2006, 72, 346-350.
  • 8Tian, H. Y.; Wang, L.; Zhang, X. Q.; Zhang, D. M.; Wang, Y.; Jiang, R. W.; Yc, W. C. New bufadicnolides and C23 steroids fi'om the venom of Bufo bufo gargarizans. Steroids 2010, 75,884-890.
  • 9Tian, H. Y.; Wang, L.; Zhang, X. Q.; Wang, Y.; Zhang, D. M.; Jiang, R. W.; Liu, Z.; Liu, J. S.; Li, Y. L; Ye, W. C. Bufogargarizins A and B, two novel 19-norbufadianolidcs with unprecedented skeletons ~om the vanom ofBufo bufo gargarizans. Chem. Fur. J. 2010, 16, 10989-10993.
  • 10Tian, H. Y.; Luo, S. L.; Liu, J. S.; Wang, L.; Wang, Y.; Zhang, D. M.; Zhang, X. Q.; Jiang, R. W.; Ye, W. C. C23 steroids from the venom of Bufo bufo gargarizans. J. Nat. Prod. 2013, 76, 1842-1847.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部